ISRCTN10288268已完成未知
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomised controlled single-centre trial
Westküstenkliniken [West Coast Hospitals]0 个研究点目标入组 110 人开始时间: 2009年2月24日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
- 2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18463831 2. 2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19493352
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All patients (both males and females, >18 years) requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least 2 concomitant Systemic Inflammatory Response Syndrome (SIRS) criteria.
排除标准
- •1. Patients who refused study consent
- •2. Patients whose antibiotic treatment had been initiated before intensive care admission
- •3. Patients who had therapy limitations
研究者
相似试验
Unknown
3 期
Procalcitonin to Shorten Antibiotics Duration in ICU PatientsSepsisNCT01379547National Taiwan University Hospital1,700
Unknown
3 期
PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) TrialSepsisNCT01652404Hunan Children's Hospital600
终止
不适用
Reduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)Lung InfectionNCT02173613University Hospital, Grenoble117
已完成
不适用
sefulness of a novel biomarker procalcitonin to guide antibiotic therapy in children with chest infectionsISRCTN17057980niversity Children's Hospital Basel (Switzerland)337
已完成
不适用
A randomised controlled trial of a procalcitonin-based algorithm to guide antibiotic use in acute pancreatitisDigestive SystemAcute pancreatitisISRCTN50584992Manchester University NHS Foundation Trust260